Highlights and Quick Summary
- EBT for the quarter ending December 31, 2022 was $-26.8 Million (a 248.52% increase compared to previous quarter)
- Year-over-year quarterly EBT increased by 38.87%
- Annual EBT for 2022 was $-80 Million (a -27.94% decrease from previous year)
- Annual EBT for 2021 was $-111 Million (a 6.16% increase from previous year)
- Annual EBT for 2020 was $-105 Million (a -38.97% decrease from previous year)
- Twelve month EBT ending December 31, 2022 was $-80 Million (a -5.75% decrease compared to previous quarter)
- Twelve month trailing EBT decreased by -26.22% year-over-year
Trailing EBT for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $-80 Million | $-84.8 Million | $-104 Million | $-108 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT of Precigen, Inc.
Most recent EBTof PGEN including historical data for past 10 years.Interactive Chart of EBT of Precigen, Inc.
Precigen, Inc. EBT for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-26.82 | $-7.69 | $-26.15 | $-19.31 | $-79.97 |
| 2021 | $-31.69 | $-26.38 | $-31.0 | $-21.9 | $-110.97 |
| 2020 | $-40.3 | $-27.59 | $-15.83 | $-20.81 | $-104.52 |
| 2019 | $-36.98 | $-49.06 | $-32.31 | $-52.91 | $-171.26 |
| 2018 | $-203.39 | $-73.07 | $-67.96 | $-51.5 | $-395.91 |
| 2017 | $16.67 | $-41.65 | $-20.48 | $-32.91 | $-78.37 |
| 2016 | $-45.5 | $-30.43 | $-50.62 | $-67.6 | $-194.15 |
| 2015 | $-33.07 | $-39.95 | $-40.56 | $26.6 | $-86.98 |
| 2014 | $17.81 | $-53.86 | $-53.22 | $3.56 | $-85.72 |
| 2013 | $-13.02 | $14.99 | $-6.52 | $-36.36 | $-40.91 |
| 2012 | $-20.49 | $-16.54 | – | – | $-81.87 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology